DGAP-News

CVR Announces Dr. Douglas Weaver as Board of Director

DGAP-News: CVR Medical Corp. / Key word(s): Miscellaneous
CVR Announces Dr. Douglas Weaver as Board of Director

15.11.2016 / 14:31
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Vancouver, British Columbia--(Newsfile Corp. - November 15, 2016) - CVR
Medical Corp. (TSXV: CVM) ('CVR Medical') is pleased to announce that CVR
Global, its joint venture partner, has named Dr. Douglas Weaver to its
Board of Directors. A renowned cardiovascular specialist, Dr. Weaver's
involvement strengthens CVR's executive leadership with extensive academic
and clinical experience.

From 2008 to 2009, Dr. Weaver was President of the American College of
Cardiology ('ACC'), a 52,000-cardiovascular care member medical society
whose mission is to transform cardiovascular care and improve heart health.
The ACC leads in the formation of health policy, standards and guidelines.
Named one of 'America's Top Doctors' by Castle Connolly, Dr. Weaver
currently serves as System Medical Director for Heart and Cardiovascular
Services for the Henry Ford Health System in Michigan. Regarded as one of
the foremost experts in his field, he has published over 300 scientific
articles, received multiple grants from leading medical research
institutions, and been appointed to lead a number of other executive and
safety committees and task forces. CVR Global and CVR Medical look forward
to having Dr. Weaver's insight and enthusiastic support as they progress
toward market launch of the 'Carotid Stenotic Scan' device.

Speaking in regards to this position, Dr. Weaver states, 'I am excited to
work with CVR on a project that fills what I believe is a void in the
diagnostic world of cardiovascular medicine. As a member of the Board, I
hope to bring a useful medical background and patient-centric viewpoint
that can assist in designing the necessary studies to prove the concept, as
well as determining the best targets for application of this great
technology.'

For additional information on the organization, leadership, and current
news please visit the newly launched company website www.CVRMed.com

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture
with CVR Global Inc. (the 'Joint Venture'). The Joint Venture operates in
the medical industry focused on the commercialization of a proprietary
subsonic, infrasonic, and low frequency sound wave analysis technology and
has patents to a diagnostic device designed to detect and measure carotid
arterial stenosis. CVR Medical is managed by a proven technical team. CVR